LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies.

导出 OA

翻译打印收藏纠错

作者： Tadeusz,Satława ^[1] ; Mateusz,Tarkowski ^[1] ; Sonia,Wróbel ^[1] ; Paweł,Dudzic ^[1] ; Tomasz,Gawłowski ^[1] ; Tomasz,Klaus ^[2] ; Marek,Orłowski ^[2] ; Anna,Kostyn ^[3] ; Sandeep,Kumar ^[2] ; Andrew,Buchanan ^[4] ; Konrad,Krawczyk ^[5]

作者单位： Natural Antibody, Kraków, Poland. ^[1] Pure Biologics, Wrocław, Poland. ^[2] Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wrocław University of Science and Technology, Wrocław, Poland. ^[3] Moderna Inc, Cambridge, Massachusetts, United States of America. ^[4] Biologics Engineering, AstraZeneca, Cambridge, United Kingdom. ^[5]

主题词抗体(Antibodies);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);概率(Probability)

DOI 10.1371/journal.pcbi.1011881

PMID 38442111

发布时间 2024-03-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交